These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 30574406

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Eschar removal by bromelain based enzymatic debridement (Nexobrid®) in burns: An European consensus.
    Hirche C, Citterio A, Hoeksema H, Koller J, Lehner M, Martinez JR, Monstrey S, Murray A, Plock JA, Sander F, Schulz A, Ziegler B, Kneser U.
    Burns; 2017 Dec; 43(8):1640-1653. PubMed ID: 29033046
    [Abstract] [Full Text] [Related]

  • 3. A Retrospective Review of an Off-label Bromelain-based Selective Enzymatic Debridement (Nexobrid®) in the Treatment of Deep, Partial, and Full Thickness Burns and Hard to Heal Wounds.
    Harats M, Haik J, Cleary M, Vashurin I, Aviv U, Kornhaber R.
    Isr Med Assoc J; 2020 Feb; 22(2):83-88. PubMed ID: 32043324
    [Abstract] [Full Text] [Related]

  • 4. To bleed or not to bleed? Case series and discussion of haemorrhage risk with enzymatic debridement in burn injuries.
    Hasham S, Riyat H, Fletcher A, O'Boyle CP, Alexander S.
    Scars Burn Heal; 2023 Feb; 9():20595131231168333. PubMed ID: 37124159
    [Abstract] [Full Text] [Related]

  • 5. Bromelain-based enzymatic burn debridement: A systematic review of clinical studies on patient safety, efficacy and long-term outcomes.
    Shoham Y, Gasteratos K, Singer AJ, Krieger Y, Silberstein E, Goverman J.
    Int Wound J; 2023 Dec; 20(10):4364-4383. PubMed ID: 37455553
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Human cadaver model as a training tool for enzymatic burn debridement (Nexobrid®): A feasibility study.
    Wen J, Johnson K, O'Boyle CP.
    Burns; 2022 Nov; 48(7):1706-1709. PubMed ID: 35210140
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Enzymatic Debridement of Deep Thermal Burns in the Russian Federation: First Experience.
    Alekseev AA, Malyutina NB, Bobrovnikov AE, Shoham Y.
    Life (Basel); 2023 Feb 10; 13(2):. PubMed ID: 36836845
    [Abstract] [Full Text] [Related]

  • 19. Eschar removal by bromelain based enzymatic debridement (Nexobrid®) in burns: European consensus guidelines update.
    Hirche C, Kreken Almeland S, Dheansa B, Fuchs P, Governa M, Hoeksema H, Korzeniowski T, Lumenta DB, Marinescu S, Martinez-Mendez JR, Plock JA, Sander F, Ziegler B, Kneser U.
    Burns; 2020 Jun 10; 46(4):782-796. PubMed ID: 32241591
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.